Learn how AI and machine learning enhance antibody discovery – from structure prediction to binding optimization – with ...

Discover what glycan analysis can reveal about protein behavior and how it can be used to boost biologic performance and ...

CRISPR construct to genetically ablate the GABA transporter GAT3 in the mouse visual cortex, with effects on population-level neuronal activity. This work is important, as it sheds light on how GAT3 ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses—using just ...

With the recent progress the company made treating the first patients in the global Phase 2B study in atopic dermatitis, and the advancements and opportunities that we are seeing broadly across I&I, ...

The announced merger with THPlasma follows Longevity's acquisition of Carmell Therapeutics (“Carmell”) in July 2023 and Elevai Skincare (“Elevai”) in January 2025. The Carmell technology platform is ...

Whole-mount 3D imaging at the cellular scale is a powerful tool for exploring complex processes during morphogenesis. In organoids, it allows examining tissue architecture, cell types, and morphology ...